Overview

Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1

Status:
Completed
Trial end date:
2001-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of flupenthixol for cocaine dependence in individuals with schizophrenia/schizoaffective illness.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborator:
New York State Psychiatric Institute
Treatments:
Cocaine
Flupenthixol
Flupenthixol decanoate